Morphine Completed Phase 4 Trials for Sickle Cell Disorders Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care4
clinicaltrials.gov IdentifierTitleDrugs
NCT02222246Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease